Delta Investment Management, LLC Alaunos Therapeutics, Inc. Transaction History

Delta Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$2.39 - $3.43 $34,557 - $49,594	-14,459 Closed	0 $0
Q2 2020 Aug 05, 2020	SELL	$2.2 - $3.71 $25,209 - $42,512	-11,459 Reduced 44.21%	14,459 $47,000
Q1 2020 May 14, 2020	SELL	$1.9 - $4.98 $12,458 - $32,653	-6,557 Reduced 20.19%	25,918 $63,000
Q4 2019 Feb 12, 2020	BUY	$3.95 - $5.35 $25,900 - $35,079	6,557 Added 25.3%	32,475 $153,000
Q3 2019 Nov 05, 2019	BUY	$4.13 - $6.94 $107,041 - $179,870	25,918 New	25,918 $110,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $398M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Delta Investment Management, LLC with notifications on news.